Table 1. Comparison of demographic data between the combined chemotherapy intervention group with Chinese traditional medicine and the chemotherapy alone control group before enrollment in the intention-to-treat population.
| Characteristic | Intervention group (n = 156) | Control group (n = 158) | P-value |
|---|---|---|---|
| Age | |||
| Median (years) | 58.9 (39–77) | 59.1 (36–78) | |
| <65 (%) | 122 (78.21) | 121 (76.58) | 0.731 |
| ≥65 (%) | 34 (21.79) | 37 (23.42) | |
| Sex- n (%) | |||
| Male | 95 (60.90) | 99 (62.66) | 0.748 |
| Female | 61 (39.10) | 59 (37.34) | |
| Disease stages at entry - n (%) | |||
| IB | 69 (44.23) | 70 (44.30) | 0.971 |
| IIA | 21 (13.46) | 23 (14.56) | |
| IIB | 15 (9.62) | 13 (8.23) | |
| IIIA | 51 (32.69) | 52 (32.91) | |
| Histology - n (%) | |||
| Squamous carcinoma | 40 (25.64) | 39 (24.68) | 0.726 |
| Adenocarcinoma | 112 (71.79) | 110 (69.62) | |
| Adenosquamous carcinoma | 3 (1.92) | 7 (4.43) | |
| Large cell carcinoma and others | 1 (0.64) | 2 (1.26) | |
| ECOG PS - n (%) | |||
| 0 | 2 (1.3) | 3 (1.9) | 0.330 |
| 1 | 152 (97.4) | 155 (98.1) | |
| 2 | 2 (1.3) | 0 (0.00) | |
Date are n (%) or median (range) for all patients with confirmed disease who received at least one cycle of the study drug. ECOG = Eastern Cooperative Oncology Group; PS = performance status.